2-[2-[amino-(4-chlorophenyl)methyl]-5-fluoro-6-(1H-pyrazol-4-yl)benzimidazol-1-yl]-N,N-dimethylethanamine;2-[2-[amino-(4-chlorophenyl)methyl]-5-fluoro-6-(1H-pyrrolo[2,3-b]pyridin-4-yl)benzimidazol-1-yl]-N,N-dimethylethanamine;3-[6-(2-aminopyrimidin-4-yl)-3H-indol-2-yl]-N,N-dimethyl-3,4-dihydro-2H-chromene-6-carboxamide;(4-chlorophenyl)-[1-ethyl-5-fluoro-6-(1H-pyrazol-4-yl)benzimidazol-2-yl]methanamine;(4-chlorophenyl)-[1-ethyl-5-fluoro-6-(1H-pyrrolo[2,3-b]pyridin-4-yl)benzimidazol-2-yl]methanamine;methyl 3-[6-(2-aminopyrimidin-4-yl)-1H-benzimidazol-2-yl]-3,4-dihydro-2H-chromene-6-carboxylate

C134H124Cl4F4N32O5 — CID 158851581

IUPAC2-[2-[amino-(4-chlorophenyl)methyl]-5-fluoro-6-(1H-pyrazol-4-yl)benzimidazol-1-yl]-N,N-dimethylethanamine;2-[2-[amino-(4-chlorophenyl)methyl]-5-fluoro-6-(1H-pyrrolo[2,3-b]pyridin-4-yl)benzimidazol-1-yl]-N,N-dimethylethanamine;3-[6-(2-aminopyrimidin-4-yl)-3H-indol-2-yl]-N,N-dimethyl-3,4-dihydro-2H-chromene-6-carboxamide;(4-chlorophenyl)-[1-ethyl-5-fluoro-6-(1H-pyrazol-4-yl)benzimidazol-2-yl]methanamine;(4-chlorophenyl)-[1-ethyl-5-fluoro-6-(1H-pyrrolo[2,3-b]pyridin-4-yl)benzimidazol-2-yl]methanamine;methyl 3-[6-(2-aminopyrimidin-4-yl)-1H-benzimidazol-2-yl]-3,4-dihydro-2H-chromene-6-carboxylate
SMILESCCn1c(C(N)c2ccc(Cl)cc2)nc2cc(F)c(-c3ccnc4[nH]ccc34)cc21.CCn1c(C(N)c2ccc(Cl)cc2)nc2cc(F)c(-c3cn[nH]c3)cc21.CN(C)C(=O)c1ccc2c(c1)CC(C1=Nc3cc(-c4ccnc(N)n4)ccc3C1)CO2.CN(C)CCn1c(C(N)c2ccc(Cl)cc2)nc2cc(F)c(-c3ccnc4[nH]ccc34)cc21.CN(C)CCn1c(C(N)c2ccc(Cl)cc2)nc2cc(F)c(-c3cn[nH]c3)cc21.COC(=O)c1ccc2c(c1)CC(c1nc3ccc(-c4ccnc(N)n4)cc3[nH]1)CO2
InChIInChI=1S/C25H24ClFN6.C24H23N5O2.C23H19ClFN5.C22H19N5O3.C21H22ClFN6.C19H17ClFN5/c1-32(2)11-12-33-22-13-19(17-7-9-29-24-18(17)8-10-30-24)20(27)14-21(22)31-25(33)23(28)15-3-5-16(26)6-4-15;1-29(2)23(30)16-5-6-22-17(9-16)10-18(13-31-22)21-12-15-4-3-14(11-20(15)27-21)19-7-8-26-24(25)28-19;1-2-30-20-11-17(15-7-9-27-22-16(15)8-10-28-22)18(25)12-19(20)29-23(30)21(26)13-3-5-14(24)6-4-13;1-29-21(28)13-3-5-19-14(8-13)9-15(11-30-19)20-25-17-4-2-12(10-18(17)26-20)16-6-7-24-22(23)27-16;1-28(2)7-8-29-19-9-16(14-11-25-26-12-14)17(23)10-18(19)27-21(29)20(24)13-3-5-15(22)6-4-13;1-2-26-17-7-14(12-9-23-24-10-12)15(21)8-16(17)25-19(26)18(22)11-3-5-13(20)6-4-11/h3-10,13-14,23H,11-12,28H2,1-2H3,(H,29,30);3-9,11,18H,10,12-13H2,1-2H3,(H2,25,26,28);3-12,21H,2,26H2,1H3,(H,27,28);2-8,10,15H,9,11H2,1H3,(H,25,26)(H2,23,24,27);3-6,9-12,20H,7-8,24H2,1-2H3,(H,25,26);3-10,18H,2,22H2,1H3,(H,23,24)
InChIKeyIZNCHVUVFCPODB-UHFFFAOYSA-N
MW2480.49 g/mol
LogP24.95
Rot. Bonds26

About 2-[2-[amino-(4-chlorophenyl)methyl]-5-fluoro-6-(1H-pyrazol-4-yl)benzimidazol-1-yl]-N,N-dimethylethanamine;2-[2-[amino-(4-chlorophenyl)methyl]-5-fluoro-6-(1H-pyrrolo[2,3-b]pyridin-4-yl)benzimidazol-1-yl]-N,N-dimethylethanamine;3-[6-(2-aminopyrimidin-4-yl)-3H-indol-2-yl]-N,N-dimethyl-3,4-dihydro-2H-chromene-6-carboxamide;(4-chlorophenyl)-[1-ethyl-5-fluoro-6-(1H-pyrazol-4-yl)benzimidazol-2-yl]methanamine;(4-chlorophenyl)-[1-ethyl-5-fluoro-6-(1H-pyrrolo[2,3-b]pyridin-4-yl)benzimidazol-2-yl]methanamine;methyl 3-[6-(2-aminopyrimidin-4-yl)-1H-benzimidazol-2-yl]-3,4-dihydro-2H-chromene-6-carboxylate

2-[2-[amino-(4-chlorophenyl)methyl]-5-fluoro-6-(1H-pyrazol-4-yl)benzimidazol-1-yl]-N,N-dimethylethanamine;2-[2-[amino-(4-chlorophenyl)methyl]-5-fluoro-6-(1H-pyrrolo[2,3-b]pyridin-4-yl)benzimidazol-1-yl]-N,N-dimethylethanamine;3-[6-(2-aminopyrimidin-4-yl)-3H-indol-2-yl]-N,N-dimethyl-3,4-dihydro-2H-chromene-6-carboxamide;(4-chlorophenyl)-[1-ethyl-5-fluoro-6-(1H-pyrazol-4-yl)benzimidazol-2-yl]methanamine;(4-chlorophenyl)-[1-ethyl-5-fluoro-6-(1H-pyrrolo[2,3-b]pyridin-4-yl)benzimidazol-2-yl]methanamine;methyl 3-[6-(2-aminopyrimidin-4-yl)-1H-benzimidazol-2-yl]-3,4-dihydro-2H-chromene-6-carboxylate (PubChem CID 158851581) has the molecular formula C134H124Cl4F4N32O5 and a molecular weight of 2480.49 g/mol. Its IUPAC name is 2-[2-[amino-(4-chlorophenyl)methyl]-5-fluoro-6-(1H-pyrazol-4-yl)benzimidazol-1-yl]-N,N-dimethylethanamine;2-[2-[amino-(4-chlorophenyl)methyl]-5-fluoro-6-(1H-pyrrolo[2,3-b]pyridin-4-yl)benzimidazol-1-yl]-N,N-dimethylethanamine;3-[6-(2-aminopyrimidin-4-yl)-3H-indol-2-yl]-N,N-dimethyl-3,4-dihydro-2H-chromene-6-carboxamide;(4-chlorophenyl)-[1-ethyl-5-fluoro-6-(1H-pyrazol-4-yl)benzimidazol-2-yl]methanamine;(4-chlorophenyl)-[1-ethyl-5-fluoro-6-(1H-pyrrolo[2,3-b]pyridin-4-yl)benzimidazol-2-yl]methanamine;methyl 3-[6-(2-aminopyrimidin-4-yl)-1H-benzimidazol-2-yl]-3,4-dihydro-2H-chromene-6-carboxylate.

Molecular Properties

Compound Name2-[2-[amino-(4-chlorophenyl)methyl]-5-fluoro-6-(1H-pyrazol-4-yl)benzimidazol-1-yl]-N,N-dimethylethanamine;2-[2-[amino-(4-chlorophenyl)methyl]-5-fluoro-6-(1H-pyrrolo[2,3-b]pyridin-4-yl)benzimidazol-1-yl]-N,N-dimethylethanamine;3-[6-(2-aminopyrimidin-4-yl)-3H-indol-2-yl]-N,N-dimethyl-3,4-dihydro-2H-chromene-6-carboxamide;(4-chlorophenyl)-[1-ethyl-5-fluoro-6-(1H-pyrazol-4-yl)benzimidazol-2-yl]methanamine;(4-chlorophenyl)-[1-ethyl-5-fluoro-6-(1H-pyrrolo[2,3-b]pyridin-4-yl)benzimidazol-2-yl]methanamine;methyl 3-[6-(2-aminopyrimidin-4-yl)-1H-benzimidazol-2-yl]-3,4-dihydro-2H-chromene-6-carboxylate
PubChem CID158851581
Molecular FormulaC134H124Cl4F4N32O5
Molecular Weight2480.49 g/mol
Exact Mass2476.91
IUPAC Name2-[2-[amino-(4-chlorophenyl)methyl]-5-fluoro-6-(1H-pyrazol-4-yl)benzimidazol-1-yl]-N,N-dimethylethanamine;2-[2-[amino-(4-chlorophenyl)methyl]-5-fluoro-6-(1H-pyrrolo[2,3-b]pyridin-4-yl)benzimidazol-1-yl]-N,N-dimethylethanamine;3-[6-(2-aminopyrimidin-4-yl)-3H-indol-2-yl]-N,N-dimethyl-3,4-dihydro-2H-chromene-6-carboxamide;(4-chlorophenyl)-[1-ethyl-5-fluoro-6-(1H-pyrazol-4-yl)benzimidazol-2-yl]methanamine;(4-chlorophenyl)-[1-ethyl-5-fluoro-6-(1H-pyrrolo[2,3-b]pyridin-4-yl)benzimidazol-2-yl]methanamine;methyl 3-[6-(2-aminopyrimidin-4-yl)-1H-benzimidazol-2-yl]-3,4-dihydro-2H-chromene-6-carboxylate
SMILESCCn1c(C(N)c2ccc(Cl)cc2)nc2cc(F)c(-c3ccnc4[nH]ccc34)cc21.CCn1c(C(N)c2ccc(Cl)cc2)nc2cc(F)c(-c3cn[nH]c3)cc21.CN(C)C(=O)c1ccc2c(c1)CC(C1=Nc3cc(-c4ccnc(N)n4)ccc3C1)CO2.CN(C)CCn1c(C(N)c2ccc(Cl)cc2)nc2cc(F)c(-c3ccnc4[nH]ccc34)cc21.CN(C)CCn1c(C(N)c2ccc(Cl)cc2)nc2cc(F)c(-c3cn[nH]c3)cc21.COC(=O)c1ccc2c(c1)CC(c1nc3ccc(-c4ccnc(N)n4)cc3[nH]1)CO2
InChIInChI=1S/C25H24ClFN6.C24H23N5O2.C23H19ClFN5.C22H19N5O3.C21H22ClFN6.C19H17ClFN5/c1-32(2)11-12-33-22-13-19(17-7-9-29-24-18(17)8-10-30-24)20(27)14-21(22)31-25(33)23(28)15-3-5-16(26)6-4-15;1-29(2)23(30)16-5-6-22-17(9-16)10-18(13-31-22)21-12-15-4-3-14(11-20(15)27-21)19-7-8-26-24(25)28-19;1-2-30-20-11-17(15-7-9-27-22-16(15)8-10-28-22)18(25)12-19(20)29-23(30)21(26)13-3-5-14(24)6-4-13;1-29-21(28)13-3-5-19-14(8-13)9-15(11-30-19)20-25-17-4-2-12(10-18(17)26-20)16-6-7-24-22(23)27-16;1-28(2)7-8-29-19-9-16(14-11-25-26-12-14)17(23)10-18(19)27-21(29)20(24)13-3-5-15(22)6-4-13;1-2-26-17-7-14(12-9-23-24-10-12)15(21)8-16(17)25-19(26)18(22)11-3-5-13(20)6-4-11/h3-10,13-14,23H,11-12,28H2,1-2H3,(H,29,30);3-9,11,18H,10,12-13H2,1-2H3,(H2,25,26,28);3-12,21H,2,26H2,1H3,(H,27,28);2-8,10,15H,9,11H2,1H3,(H,25,26)(H2,23,24,27);3-6,9-12,20H,7-8,24H2,1-2H3,(H,25,26);3-10,18H,2,22H2,1H3,(H,23,24)
InChIKeyIZNCHVUVFCPODB-UHFFFAOYSA-N
XLogP24.95
TPSA506.27 Ų
H-Bond Donors11
H-Bond Acceptors31
Rotatable Bonds26
Heavy Atoms179
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002480.49
LogP ≤ 524.95
H-Bond Donors ≤ 511
H-Bond Acceptors ≤ 1031

Analyze 2-[2-[amino-(4-chlorophenyl)methyl]-5-fluoro-6-(1H-pyrazol-4-yl)benzimidazol-1-yl]-N,N-dimethylethanamine;2-[2-[amino-(4-chlorophenyl)methyl]-5-fluoro-6-(1H-pyrrolo[2,3-b]pyridin-4-yl)benzimidazol-1-yl]-N,N-dimethylethanamine;3-[6-(2-aminopyrimidin-4-yl)-3H-indol-2-yl]-N,N-dimethyl-3,4-dihydro-2H-chromene-6-carboxamide;(4-chlorophenyl)-[1-ethyl-5-fluoro-6-(1H-pyrazol-4-yl)benzimidazol-2-yl]methanamine;(4-chlorophenyl)-[1-ethyl-5-fluoro-6-(1H-pyrrolo[2,3-b]pyridin-4-yl)benzimidazol-2-yl]methanamine;methyl 3-[6-(2-aminopyrimidin-4-yl)-1H-benzimidazol-2-yl]-3,4-dihydro-2H-chromene-6-carboxylate with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 2-[2-[amino-(4-chlorophenyl)methyl]-5-fluoro-6-(1H-pyrazol-4-yl)benzimidazol-1-yl]-N,N-dimethylethanamine;2-[2-[amino-(4-chlorophenyl)methyl]-5-fluoro-6-(1H-pyrrolo[2,3-b]pyridin-4-yl)benzimidazol-1-yl]-N,N-dimethylethanamine;3-[6-(2-aminopyrimidin-4-yl)-3H-indol-2-yl]-N,N-dimethyl-3,4-dihydro-2H-chromene-6-carboxamide;(4-chlorophenyl)-[1-ethyl-5-fluoro-6-(1H-pyrazol-4-yl)benzimidazol-2-yl]methanamine;(4-chlorophenyl)-[1-ethyl-5-fluoro-6-(1H-pyrrolo[2,3-b]pyridin-4-yl)benzimidazol-2-yl]methanamine;methyl 3-[6-(2-aminopyrimidin-4-yl)-1H-benzimidazol-2-yl]-3,4-dihydro-2H-chromene-6-carboxylate?
The IUPAC name of 2-[2-[amino-(4-chlorophenyl)methyl]-5-fluoro-6-(1H-pyrazol-4-yl)benzimidazol-1-yl]-N,N-dimethylethanamine;2-[2-[amino-(4-chlorophenyl)methyl]-5-fluoro-6-(1H-pyrrolo[2,3-b]pyridin-4-yl)benzimidazol-1-yl]-N,N-dimethylethanamine;3-[6-(2-aminopyrimidin-4-yl)-3H-indol-2-yl]-N,N-dimethyl-3,4-dihydro-2H-chromene-6-carboxamide;(4-chlorophenyl)-[1-ethyl-5-fluoro-6-(1H-pyrazol-4-yl)benzimidazol-2-yl]methanamine;(4-chlorophenyl)-[1-ethyl-5-fluoro-6-(1H-pyrrolo[2,3-b]pyridin-4-yl)benzimidazol-2-yl]methanamine;methyl 3-[6-(2-aminopyrimidin-4-yl)-1H-benzimidazol-2-yl]-3,4-dihydro-2H-chromene-6-carboxylate (CID 158851581) is 2-[2-[amino-(4-chlorophenyl)methyl]-5-fluoro-6-(1H-pyrazol-4-yl)benzimidazol-1-yl]-N,N-dimethylethanamine;2-[2-[amino-(4-chlorophenyl)methyl]-5-fluoro-6-(1H-pyrrolo[2,3-b]pyridin-4-yl)benzimidazol-1-yl]-N,N-dimethylethanamine;3-[6-(2-aminopyrimidin-4-yl)-3H-indol-2-yl]-N,N-dimethyl-3,4-dihydro-2H-chromene-6-carboxamide;(4-chlorophenyl)-[1-ethyl-5-fluoro-6-(1H-pyrazol-4-yl)benzimidazol-2-yl]methanamine;(4-chlorophenyl)-[1-ethyl-5-fluoro-6-(1H-pyrrolo[2,3-b]pyridin-4-yl)benzimidazol-2-yl]methanamine;methyl 3-[6-(2-aminopyrimidin-4-yl)-1H-benzimidazol-2-yl]-3,4-dihydro-2H-chromene-6-carboxylate.
What is the SMILES notation for 2-[2-[amino-(4-chlorophenyl)methyl]-5-fluoro-6-(1H-pyrazol-4-yl)benzimidazol-1-yl]-N,N-dimethylethanamine;2-[2-[amino-(4-chlorophenyl)methyl]-5-fluoro-6-(1H-pyrrolo[2,3-b]pyridin-4-yl)benzimidazol-1-yl]-N,N-dimethylethanamine;3-[6-(2-aminopyrimidin-4-yl)-3H-indol-2-yl]-N,N-dimethyl-3,4-dihydro-2H-chromene-6-carboxamide;(4-chlorophenyl)-[1-ethyl-5-fluoro-6-(1H-pyrazol-4-yl)benzimidazol-2-yl]methanamine;(4-chlorophenyl)-[1-ethyl-5-fluoro-6-(1H-pyrrolo[2,3-b]pyridin-4-yl)benzimidazol-2-yl]methanamine;methyl 3-[6-(2-aminopyrimidin-4-yl)-1H-benzimidazol-2-yl]-3,4-dihydro-2H-chromene-6-carboxylate?
The canonical SMILES for 2-[2-[amino-(4-chlorophenyl)methyl]-5-fluoro-6-(1H-pyrazol-4-yl)benzimidazol-1-yl]-N,N-dimethylethanamine;2-[2-[amino-(4-chlorophenyl)methyl]-5-fluoro-6-(1H-pyrrolo[2,3-b]pyridin-4-yl)benzimidazol-1-yl]-N,N-dimethylethanamine;3-[6-(2-aminopyrimidin-4-yl)-3H-indol-2-yl]-N,N-dimethyl-3,4-dihydro-2H-chromene-6-carboxamide;(4-chlorophenyl)-[1-ethyl-5-fluoro-6-(1H-pyrazol-4-yl)benzimidazol-2-yl]methanamine;(4-chlorophenyl)-[1-ethyl-5-fluoro-6-(1H-pyrrolo[2,3-b]pyridin-4-yl)benzimidazol-2-yl]methanamine;methyl 3-[6-(2-aminopyrimidin-4-yl)-1H-benzimidazol-2-yl]-3,4-dihydro-2H-chromene-6-carboxylate is CCn1c(C(N)c2ccc(Cl)cc2)nc2cc(F)c(-c3ccnc4[nH]ccc34)cc21.CCn1c(C(N)c2ccc(Cl)cc2)nc2cc(F)c(-c3cn[nH]c3)cc21.CN(C)C(=O)c1ccc2c(c1)CC(C1=Nc3cc(-c4ccnc(N)n4)ccc3C1)CO2.CN(C)CCn1c(C(N)c2ccc(Cl)cc2)nc2cc(F)c(-c3ccnc4[nH]ccc34)cc21.CN(C)CCn1c(C(N)c2ccc(Cl)cc2)nc2cc(F)c(-c3cn[nH]c3)cc21.COC(=O)c1ccc2c(c1)CC(c1nc3ccc(-c4ccnc(N)n4)cc3[nH]1)CO2.
What is the InChIKey of 2-[2-[amino-(4-chlorophenyl)methyl]-5-fluoro-6-(1H-pyrazol-4-yl)benzimidazol-1-yl]-N,N-dimethylethanamine;2-[2-[amino-(4-chlorophenyl)methyl]-5-fluoro-6-(1H-pyrrolo[2,3-b]pyridin-4-yl)benzimidazol-1-yl]-N,N-dimethylethanamine;3-[6-(2-aminopyrimidin-4-yl)-3H-indol-2-yl]-N,N-dimethyl-3,4-dihydro-2H-chromene-6-carboxamide;(4-chlorophenyl)-[1-ethyl-5-fluoro-6-(1H-pyrazol-4-yl)benzimidazol-2-yl]methanamine;(4-chlorophenyl)-[1-ethyl-5-fluoro-6-(1H-pyrrolo[2,3-b]pyridin-4-yl)benzimidazol-2-yl]methanamine;methyl 3-[6-(2-aminopyrimidin-4-yl)-1H-benzimidazol-2-yl]-3,4-dihydro-2H-chromene-6-carboxylate?
The InChIKey is IZNCHVUVFCPODB-UHFFFAOYSA-N. The full InChI is InChI=1S/C25H24ClFN6.C24H23N5O2.C23H19ClFN5.C22H19N5O3.C21H22ClFN6.C19H17ClFN5/c1-32(2)11-12-33-22-13-19(17-7-9-29-24-18(17)8-10-30-24)20(27)14-21(22)31-25(33)23(28)15-3-5-16(26)6-4-15;1-29(2)23(30)16-5-6-22-17(9-16)10-18(13-31-22)21-12-15-4-3-14(11-20(15)27-21)19-7-8-26-24(25)28-19;1-2-30-20-11-17(15-7-9-27-22-16(15)8-10-28-22)18(25)12-19(20)29-23(30)21(26)13-3-5-14(24)6-4-13;1-29-21(28)13-3-5-19-14(8-13)9-15(11-30-19)20-25-17-4-2-12(10-18(17)26-20)16-6-7-24-22(23)27-16;1-28(2)7-8-29-19-9-16(14-11-25-26-12-14)17(23)10-18(19)27-21(29)20(24)13-3-5-15(22)6-4-13;1-2-26-17-7-14(12-9-23-24-10-12)15(21)8-16(17)25-19(26)18(22)11-3-5-13(20)6-4-11/h3-10,13-14,23H,11-12,28H2,1-2H3,(H,29,30);3-9,11,18H,10,12-13H2,1-2H3,(H2,25,26,28);3-12,21H,2,26H2,1H3,(H,27,28);2-8,10,15H,9,11H2,1H3,(H,25,26)(H2,23,24,27);3-6,9-12,20H,7-8,24H2,1-2H3,(H,25,26);3-10,18H,2,22H2,1H3,(H,23,24).
What are the key properties of 2-[2-[amino-(4-chlorophenyl)methyl]-5-fluoro-6-(1H-pyrazol-4-yl)benzimidazol-1-yl]-N,N-dimethylethanamine;2-[2-[amino-(4-chlorophenyl)methyl]-5-fluoro-6-(1H-pyrrolo[2,3-b]pyridin-4-yl)benzimidazol-1-yl]-N,N-dimethylethanamine;3-[6-(2-aminopyrimidin-4-yl)-3H-indol-2-yl]-N,N-dimethyl-3,4-dihydro-2H-chromene-6-carboxamide;(4-chlorophenyl)-[1-ethyl-5-fluoro-6-(1H-pyrazol-4-yl)benzimidazol-2-yl]methanamine;(4-chlorophenyl)-[1-ethyl-5-fluoro-6-(1H-pyrrolo[2,3-b]pyridin-4-yl)benzimidazol-2-yl]methanamine;methyl 3-[6-(2-aminopyrimidin-4-yl)-1H-benzimidazol-2-yl]-3,4-dihydro-2H-chromene-6-carboxylate?
2-[2-[amino-(4-chlorophenyl)methyl]-5-fluoro-6-(1H-pyrazol-4-yl)benzimidazol-1-yl]-N,N-dimethylethanamine;2-[2-[amino-(4-chlorophenyl)methyl]-5-fluoro-6-(1H-pyrrolo[2,3-b]pyridin-4-yl)benzimidazol-1-yl]-N,N-dimethylethanamine;3-[6-(2-aminopyrimidin-4-yl)-3H-indol-2-yl]-N,N-dimethyl-3,4-dihydro-2H-chromene-6-carboxamide;(4-chlorophenyl)-[1-ethyl-5-fluoro-6-(1H-pyrazol-4-yl)benzimidazol-2-yl]methanamine;(4-chlorophenyl)-[1-ethyl-5-fluoro-6-(1H-pyrrolo[2,3-b]pyridin-4-yl)benzimidazol-2-yl]methanamine;methyl 3-[6-(2-aminopyrimidin-4-yl)-1H-benzimidazol-2-yl]-3,4-dihydro-2H-chromene-6-carboxylate has a molecular weight of 2480.49 g/mol, XLogP of 24.95, 26 rotatable bonds, 11 hydrogen bond donors, and 31 hydrogen bond acceptors.
Where does this data come from?
All data for 2-[2-[amino-(4-chlorophenyl)methyl]-5-fluoro-6-(1H-pyrazol-4-yl)benzimidazol-1-yl]-N,N-dimethylethanamine;2-[2-[amino-(4-chlorophenyl)methyl]-5-fluoro-6-(1H-pyrrolo[2,3-b]pyridin-4-yl)benzimidazol-1-yl]-N,N-dimethylethanamine;3-[6-(2-aminopyrimidin-4-yl)-3H-indol-2-yl]-N,N-dimethyl-3,4-dihydro-2H-chromene-6-carboxamide;(4-chlorophenyl)-[1-ethyl-5-fluoro-6-(1H-pyrazol-4-yl)benzimidazol-2-yl]methanamine;(4-chlorophenyl)-[1-ethyl-5-fluoro-6-(1H-pyrrolo[2,3-b]pyridin-4-yl)benzimidazol-2-yl]methanamine;methyl 3-[6-(2-aminopyrimidin-4-yl)-1H-benzimidazol-2-yl]-3,4-dihydro-2H-chromene-6-carboxylate is sourced from PubChem (CID 158851581), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).